Alissa Marr, M.D.

Alissa Marr, M.D.
Assistant Professor, Internal MedicineAlissa Marr, M.D.
Division of Oncology & Hematology

Academic Office mailing address:
UNMC Oncology/Hematology Division
986840 Nebraska Medical Center
Omaha, NE 68198-6840

Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fax: 402-559-6520

Practice Locations:
Fred & Pamela Buffett Cancer Center
986840 Nebraska Medical Center
Omaha, NE 68198-6840 (map)

Nebraska Medicine Village Pointe
111 North 175th Street
Omaha, NE 68118
Ph. 402-596-3100 (map)

Education:
University of Nebraska Medical Center, Resident (2006)
University of Nebraska Medical Center, Chief Resident (2007)
University of Nebraska Medical Center, Fellow (2010)
Texas Christian University, B.S. (1999)
University of Nebraska Medical Center, M.D. (2003)

Hospital Appointments:
Nebraska Medicine

Interests:
Novel therapies for the treatment of lung cancer and malignant melanoma.

Biographical Sketch:
Dr. Marr is an Assistant Professor of Medicine at the University of Nebraska Medical Center. She received all of her medical education and training at UNMC and joined the faculty in 2010. Dr. Marr is actively engaged in medical practice, teaching and clinical research and specializes in the care of patients with malignant melanoma and lung cancer at the University of Nebraska Medical Center.

Select Publications:
Chakraborty S, Ganti A, Marr A, Batra S. Lung Cancer in Women: Role of Estrogens. Expert Review of Resp
Medicine, 2010; 4(4):509-518.
Armitage JO, Marr A. Therapeutic Approaches in Non-Hodgkin’s Lymphoma: A Case Review.

Clinical Care
Options Oncology, Nov. 16, 2009.

Gajra A, Marr AS and Ganti AK. Management of Patients with Lung Cancer and Poor Performance Status. J Natl Compr Canc Netw2014 Jul; 12(7): 1015-25.

Marr AS, Ganti AK. Advanced Lung Cancer in the Older Patient: Is there a Role for Bevacizumab? J Thoracic Dis 2012; 4(6):629-630

Marr AS, Silva E and Silberstein P. VA Hospital System Guidelines for the Management of Melanoma. Federal Practitioner 2011; 28: Suppl 6, pp 8-11

Ganti AK, Siedlik E, Marr AS, Loberiza FR, Kessinger A. Predictive Ability of Charlson Comorbidity Index on Outcomes from Lung Cancer. Am J Clin Oncol 2011: 34(6):593-596

Additional Publications at PubMed.Gov: https://www.ncbi.nlm.nih.gov/pubmed